**vartis launches Neupogen copycat Zarxio in U.S. market
 

**vartis launches Neupogen copycat Zarxio in U.S. market
ZURICH, Sept 3 (Reuters) - **vartis AG has launched the first biosimilar drug in the United States after a U.S. appeals court declined on Wednesday to stop the sale of the company's copycat version of Amgen Inc's blockbuster cancer drug Neupogen.
http://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...nQ:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...nQ:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/45anKDcGFqM